Catherine Longeval is a premier name in life sciences in Belgium who is sought after for her excellent product liability defence work.
Catherine is a partner in Van Bael & Bellis’ Brussels office where she heads the litigation department and co-heads the life sciences practice. She specialises in litigation before the Belgian courts with a particular emphasis on life sciences law, distribution law and unfair market practices. As regards life sciences law, she advises clients on a wide range of issues regarding the legislation governing medicines, biotech products, medical devices, cosmetics, food supplements and related products.
Catherine is recommended by all leading directories for her work in life sciences and dispute resolution, including Chambers and Partners, Expert Guides’ Guide to the World's Leading Litigation Lawyers, The Legal 500, Best Lawyers and European Legal Experts. In addition, she has contributed to the following publications: PLC's Life Sciences Cross-border Handbook; the Commented Codex Pharma – Public Health in Belgium (Knops Publishing); and the Chambers Global practice guides Pharmaceutical Advertising and EU Life Sciences. She regularly speaks at, and chairs, seminars on life sciences law.
Catherine graduated from the Catholic University of Leuven in 1987 and holds a master’s degree in European law from the Université Libre de Bruxelles (1989). She is a member of the Brussels Pharma Law Group and of the Belgian Centre for Mediation and Arbitration (CEPINA). Catherine practises in Dutch, French and English.
Van Bael & Bellis is regularly ranked as one of the leading law firms in Belgium specialising in the field of life sciences regulatory law at both Belgian and pan-European level. The firm is also highly recommended by leading directories for intellectual property and product liability matters in the life sciences field.